| Announce Date | 11/25/2025 |
| EPS Normalized Actual | $0.66 (Miss by $-0.65) |
| EPS GAAP Actual | $0.66 (Miss by $-0.65) |
| Revenue Actual | $9.672B |
| Revenue Surprise | Beat by $9672M |
| Announce Date | 02/04/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.71593 |
| EPS GAAP Estimate | $2.71593 |
| Revenue Estimate | $14.283359833B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Feb 2030 | 12.56 | 5.34 | 12.31095 | 12.89512 | 1 |
| Feb 2029 | 11.63 | 5.76 | 11.2544 | 12.0656 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.67 | 0.67 | 9.672B | 2.35% | 9672M |
| FQ3 2025 (Aug 2025) | 0.88 | 0.88 | 9.438B | 1.59% | 9438M |
| FQ2 2025 (May 2025) | 0.95 | 0.95 | 8.767B | -0.91% | 8767M |
| FQ1 2025 (Feb 2025) | 0.55 | 0.55 | 13.948B | -5% | 13948M |
| FQ4 2024 (Nov 2024) | -2.49 | -2.49 | 9.445B | -3.29% | 9445M |
| FQ3 2024 (Aug 2024) | 1.35 | 1.35 | 9.288B | -3.18% | 9288M |
| FQ2 2024 (May 2024) | 1.14 | 1.14 | 8.847B | -7.01% | 8847M |
| FQ1 2024 (Feb 2024) | 2.12 | 2.12 | 14.646B | 100% | 14646M |
FQ4 Announce Date
02/04/2026 (Pre-Market)
Consensus EPS Estimates
2.71593
Consensus Revenue Estimates
14.283359833B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Nov 2027) | 1.56485 | -- | 1.54382 | 1.58828 | 4 |
| FQ3 2027 (Aug 2027) | 1.52946 | -- | 1.50891 | 1.55236 | 4 |
| FQ2 2027 (May 2027) | 1.3443 | -- | 1.32624 | 1.36443 | 8 |
| FQ1 2027 (Feb 2027) | 2.78871 | -- | 2.70799 | 2.85927 | 9 |
| FQ4 2026 (Oct 2026) | 1.50506 | 55.48 | 1.43356 | 1.54259 | 20 |
| FQ3 2026 (Jul 2026) | 1.55425 | 43.38 | 1.48042 | 1.593 | 10 |
| FQ2 2026 (Apr 2026) | 1.22784 | 22.63 | 1.16951 | 1.25846 | 13 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Nov 2027) | 9.12B | -- | 9.02B | 9.22B | 5 |
| FQ3 2027 (Aug 2027) | 9.19B | -- | 9.09B | 9.29B | 5 |
| FQ2 2027 (May 2027) | 9.25B | -- | 9.16B | 9.36B | 5 |
| FQ1 2027 (Feb 2027) | 9.5B | -- | 9.29B | 9.69B | 12 |
| FQ4 2026 (Oct 2026) | 9.75B | 0.76 | 9.39B | 9.93B | 21 |
| FQ3 2026 (Jul 2026) | 9.51B | 0.76 | 9.16B | 9.69B | 11 |
| FQ2 2026 (Apr 2026) | 9B | 2.64 | 8.68B | 9.18B | 14 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.67 | 0.67 | 100% | |
| FQ3 2025 (Aug 2025) | 0.88 | 0.88 | 100% | |
| FQ2 2025 (May 2025) | 0.95 | 0.95 | 100% | |
| FQ1 2025 (Feb 2025) | 0.55 | 0.55 | 100% | |
| FQ4 2024 (Nov 2024) | -2.49 | -2.49 | 100% | |
| FQ3 2024 (Aug 2024) | 1.35 | 1.35 | 100% | |
| FQ2 2024 (May 2024) | 1.14 | 1.14 | 100% | |
| FQ1 2024 (Feb 2024) | 2.12 | 2.12 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $9.67B | $9672M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $9.44B | $9438M | 100% |
| FQ2 2025 (May 2025) | $0B | $8.77B | $8767M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $13.95B | $13948M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $9.45B | $9445M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $9.29B | $9288M | 100% |
| FQ2 2024 (May 2024) | $0B | $8.85B | $8847M | 100% |
| FQ1 2024 (Feb 2024) | $0B | $14.65B | $14646M | 100% |